Romosozumab
- Part D specialty tier in 65% of formularies (2026Q3)
- Biologic
- Evenity
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Romosozumab: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Refrigerate EVENITY at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
- Freezing
- Do not freeze
Label statement
Do not freeze.
- Room temperature
- up to 30 days at or below 25°C (77°F)
Label statement
If removed from the refrigerator, EVENITY can be kept at room temperature up to 25°C (77°F) in the original carton and must be used within 30 days.
- Back into the refrigerator
- Not addressed
- Light
- Protect from light
Label statement
Refrigerate EVENITY at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
- Shaking
- Do not shake
Label statement
Do not shake.
All storage statements on the label (6)
- Refrigerate EVENITY at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
- Do not freeze.
- Do not shake.
- If removed from the refrigerator, EVENITY can be kept at room temperature up to 25°C (77°F) in the original carton and must be used within 30 days.
- If not used within 30 days, discard EVENITY.
- Do not expose EVENITY to temperatures above 25°C (77°F).
FDA label version 21, effective July 16, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.